Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain

被引：0
作者：
Carole Dembek
Leigh Ann White
Jayson Quach
Andrea Szkurhan
Nazia Rashid
M. R. Blasco
机构：
[1] Avalere Health,
[2] Biogen Idec,undefined
[3] Dymaxium,undefined
[4] Hospital Universitario Puerta de Hierro,undefined
来源：
The European Journal of Health Economics | 2014年 / 15卷
关键词：
Multiple sclerosis; Cost-effectiveness; Disease-modifying therapies; Interferon-beta; I1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 362
页数：9
相关论文
共 86 条
[61]  
Weinshenker BG(undefined)undefined undefined undefined undefined-undefined
[62]  
Bass B(undefined)undefined undefined undefined undefined-undefined
[63]  
Rice GP(undefined)undefined undefined undefined undefined-undefined
[64]  
Earnshaw SR(undefined)undefined undefined undefined undefined-undefined
[65]  
Graham J(undefined)undefined undefined undefined undefined-undefined
[66]  
Oleen-Burkey MK(undefined)undefined undefined undefined undefined-undefined
[67]  
Runmarker B(undefined)undefined undefined undefined undefined-undefined
[68]  
Andersen O(undefined)undefined undefined undefined undefined-undefined
[69]  
Broman T(undefined)undefined undefined undefined undefined-undefined
[70]  
Andersen O(undefined)undefined undefined undefined undefined-undefined
123456789